News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ColBar LifeScience Ltd. Completes $7.25 Million Round Led By Vitalife; Vitalife Joins Existing Investors Pitango, Evergreen, Genesis And Biomedical Investments In Current Round



10/19/2005 5:10:19 PM

Colbar, the Israeli manufacturer of reconstructive medicine and tissue engineering products, today announced the completion of a $7.25 million financing round. Vitalife, the Israeli life sciences venture capital fund, led the round and was joined by previous investors Pitango Venture Capital, Evergreen Partners, Genesis Partners, and Biomedical Investments.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES